GlassScriptPhysician profile
Yuna Rapoport
NPI 1144516121
$89,955.46
in general payments reported to CMS, 2019-2025
26 companies · $37K in 2025
The $37K reported for 2025 was more than what 98% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,561 · 2020: $1,462 · 2021: $757 · 2022: $14K · 2023: $10K · 2024: $24K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $8,174 · Travel and Lodging: $6,691 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,745 · Education: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,625.00 |
| Food and Beverage | $8,174.10 |
| Travel and Lodging | $6,691.37 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,745.08 |
| Education | $1,437.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $29,168.12 | 2021-2025 | Tearcare System, Omni Surgical System, Sion Surgical Instrument |
| Tarsus Pharmaceuticals, INC. | $19,030.17 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec, INC. | $14,318.70 | 2019-2025 | Visumax |
| Bausch & Lomb Americas INC. | $12,210.29 | 2022-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Alcon Research LLC | $3,000.00 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $2,061.37 | 2019-2025 | Tecnis Simplicity, Tecnis Iol |
| Oyster Point Pharma, INC. | $1,644.87 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $1,577.71 | 2019-2025 | Cequa, Xelpros |
| Allergan, INC. | $1,351.33 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $1,098.37 | 2023-2025 | Acthar |
| Tersera Therapeutics LLC | $950.00 | 2023 | |
| Harrow Eye, LLC | $638.57 | 2024-2025 | Vevye, Ilevro |
| Dompe US, INC. | $489.75 | 2022-2024 | Oxervate |
| Alcon Vision LLC | $478.10 | 2019-2025 | Clareon, Tryptyr |
| Abbvie INC. | $409.21 | 2022-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $368.00 | 2019 | |
| Glaukos Corporation | $301.92 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $218.21 | 2021-2022 | |
| Haag-Streit USA, INC. | $168.36 | 2024 | |
| Aerie Pharmaceuticals, INC. | $156.48 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $125.01 | 2021-2022 | |
| Ocular Therapeutix, INC. | $93.83 | 2019 | |
| Astellas Pharma US INC | $28.21 | 2024 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $26.86 | 2021 | |
| Eyevance Pharmaceuticals LLC | $22.44 | 2019 | |
| Horizon Therapeutics Plc | $19.58 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuna Rapoport listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.